Novel cephalosporin compounds
    1.
    发明公开
    Novel cephalosporin compounds 失效
    新型头孢菌素化合物

    公开(公告)号:EP0335390A2

    公开(公告)日:1989-10-04

    申请号:EP89105616.0

    申请日:1989-03-30

    摘要: Cephalosporin compounds represented by the general formula
    in which R¹ is a hydrogen atom or a protective group for the amino group,
    R² is a hydrogen atom or a protective group for the hydroxyl group,
    R³ is a hydrogen atom, a self-forming cation or a protective group for the carboxyl group, and
    R⁴ is a hydrogen atom, a halogen atom or a lower alkyl group,
    and their pharmacologically acceptable salts, process for their production and use of the same compounds as medica­ments, particularly as antibiotic agents.

    摘要翻译: 由通式表示的头孢菌素化合物,其中R 1是氢原子或氨基的保护基,R 2是氢原子或羟基的保护基,R 3是氢原子,自生阳离子或 羧基保护基,R 4是氢原子,卤素原子或低级烷基,及其药理学上可接受的盐,它们的制备方法及其与药物相同的化合物的用途,特别是作为抗生素剂。

    Novel cephalosporin compounds
    3.
    发明公开
    Novel cephalosporin compounds 失效
    新型CEPHOLOSPORIN化合物

    公开(公告)号:EP0335390A3

    公开(公告)日:1991-05-02

    申请号:EP89105616.0

    申请日:1989-03-30

    摘要: Cephalosporin compounds represented by the general formula
    in which R¹ is a hydrogen atom or a protective group for the amino group,
    R² is a hydrogen atom or a protective group for the hydroxyl group,
    R³ is a hydrogen atom, a self-forming cation or a protective group for the carboxyl group, and
    R⁴ is a hydrogen atom, a halogen atom or a lower alkyl group,
    and their pharmacologically acceptable salts, process for their production and use of the same compounds as medica­ments, particularly as antibiotic agents.

    Beta-lactam compounds and process for the preparation thereof
    9.
    发明公开
    Beta-lactam compounds and process for the preparation thereof 失效
    Beta-Lactamderivate和Verfahren zu ihrer Herstellung。

    公开(公告)号:EP0082498A2

    公开(公告)日:1983-06-29

    申请号:EP82111732.2

    申请日:1982-12-17

    摘要: There are disclosed a compound having the following formula:
    in which R 1 denotes a substituted or unsubstituted thiazolyl radical, a substituted or unsubstituted thiazolylmercapto radical or a substituted or unsubstituted phenyl radical; R 2 denotes a halogen atom, a cyano radical, a carbamoyl radical, a lower-alkylmercapto radical or an 0-lower-alkylcarboxyimidoyl radical; and Y represents a group
    (wherein R 3 denotes hydrogen, a salt forming cation or a protective group for a carboxylic acid, and R denotes hydrogen or a residue of a nucleophilic compound); process for preparing the same; and an intermediate compound useful for preparing the same.
    The above mentioned compound has a broad antibacterial spectrum and shows strong antibacterial activities against not only gram-positive bacteria but also gram-negative bacteria, particularly the resistive gram-negative becteria.

    摘要翻译: 公开了具有下式的化合物:其中R 1表示取代或未取代的噻唑基,取代或未取代的噻唑基巯基或取代或未取代的苯基的 R 2表示卤素原子,氰基,氨基甲酰基,低级烷基巯基或O-低级烷基羧基亚氨基; Y表示(其中R 3表示氢,成盐阳离子或羧酸保护基,R 4表示氢或亲核化合物的残基)。 制备方法; 和可用于制备该中间体的中间体化合物。 上述化合物具有广泛的抗菌谱,并且对革兰氏阳性细菌,革兰氏阴性细菌,特别是抗性革兰氏阴性菌也表现出强烈的抗菌活性。